Fully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott realTime CMV assay in the era of the CMV international standard

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2096-2102

  Schnepf, Nathalie ^a,b   Scieux, Catherine ^a   Resche Riggon, Matthieu ^a   Feghoul, Linda ^a   Xhaard, Alienor ^a   Gallien, Sébastien ^a   Molina, Jean Michel ^a   Socié, Gérard ^a   Viglietti, Denis ^a   Simon, François ^a   Mazeron, Marie Christine ^a,b   LeGoff, Jérôme ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSAY; AUTOMATION; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOMEGALOVIRUS; HUMAN; LIMIT OF QUANTITATION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; VALIDATION PROCESS; VIRUS DETECTION; VIRUS LOAD; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; GENETICS; ISOLATION AND PURIFICATION; LABORATORY AUTOMATION; LABORATORY DIAGNOSIS; MOLECULAR DIAGNOSIS; PROCEDURES; SENSITIVITY AND SPECIFICITY; STANDARDS; VIROLOGY;

CYTOMEGALOVIRUS;

AUTOMATION, LABORATORY; BLOOD; CYTOMEGALOVIRUS; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VIRAL LOAD;

EID: 84879447038     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00067-13     Document Type: Article

References (26)

1. Beam E, Razonable RR. 2012. Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment. Curr. Infect. Dis. Rep. 14:633-641.
2. Ljungman P, Hakki M, Boeckh M. 2011. Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol. Oncol. Clin. North Am. 25:151-169.
3. Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. 2000. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355:2032-2036.
4. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Snydman DR, Allen U, Humar A, Transplantation Society International CMV Consensus Group. 2010. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation 89:779-795.
5. Baldanti F, Lilleri D, Gerna G. 2008. Monitoring human cytomegalovirus infection in transplant recipients. J. Clin. Virol. 41:237-241.
6. Gerna G, Lilleri D, Chiesa A, Zelini P, Furione M, Comolli G, Pellegrini C, Sarchi E, Migotto C, Bonora MR, Meloni F, Arbustini E. 2011. Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. Am. J. Transplant. 11: 2463-2471.
7. Cardeñoso L, Pinsky BA, Lautenschlager I, Aslam S, Cobb B, Vilchez RA, Hirsch HH. 2013. CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients. J. Clin. Virol. 56:108-112.
8. Piiparinen H, Hockerstedt K, Gronhagen-Riska C, Lautenschlager I. 2004. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients. J. Clin. Virol. 30:258-266.
9. Lee AV, Atkinson C, Manuel RJ, Clark DA. 2011. Comparative evaluation of the QIAGEN QIAsymphony® SP system and bioMerieux NucliSens easyMAG automated extraction platforms in a clinical virology laboratory. J. Clin. Virol. 52:339-343.
10. Mengelle C, Mansuy JM, Da Silva I, Davrinche C, Izopet J. 2011. Comparison of 2 highly automated nucleic acid extraction systems for quantitation of human cytomegalovirus in whole blood. Diagn. Microbiol. Infect. Dis. 69:161-166.
11. Mengelle C, Mansuy JM, Saune K, Barthe C, Boineau J, Izopet J. 2012. A new highly automated extraction system for quantitative real-time PCRs from whole blood samples: routine monitoring of opportunistic infections in immunosuppressed patients. J. Clin. Virol. 53:314-319.
12. Pang XL, Fox JD, Fenton JM, Miller GG, Caliendo AM, Preiksaitis JK. 2009. Interlaboratory comparison of cytomegalovirus viral load assays. Am. J. Transplant. 9:258-268.
13. Hayden RT, Yan X, Wick MT, Rodriguez AB, Xiong X, Ginocchio CC, Mitchell MJ, Caliendo AM. 2012. Factors contributing to variability of quantitative viralPCRresults in proficiency testing samples: a multivariate analysis. J. Clin. Microbiol. 50:337-345.
14. Wolff DJ, Heaney DL, Neuwald PD, Stellrecht KA, Press RD. 2009. Multi-Site PCR-basedCMVviral load assessment-assays demonstrate linearity and precision, but lack numeric standardization: a report of the association for molecular pathology. J. Mol. Diagn. 11:87-92.
15. Freyer JF, WHO Expert Committee on Biological Standardization. 2010. Collaborative study to evaluate the proposed 1st WHO International Standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays. WHO/BS/10.2138. World Health Organization, Geneva, Switzerland.
16. Lin LI. 1989. A concordance correlation coefficient to evaluate reproducibility. Biometrics 45:255-268.
17. Barnhart HX, Song J, Lyles RH. 2005. Assay validation for left-censored data. Stat. Med. 24:3347-3360.
18. Andrews PA, Emery VC, Newstead C. 2011. Summary of the British Transplantation Society guidelines for the prevention and management of CMV disease after solid organ transplantation. Transplantation 92:1181-1187.
19. Ljungman P. 2008. CMV infections after hematopoietic stem cell transplantation. Bone Marrow Transplant. 42(Suppl 1):S70-S72.
20. Deback C, Geli J, Ait-Arkoub Z, Angleraud F, Gautheret-Dejean A, Agut H, Boutolleau D. 2009. Use of the Roche LightCycler 480 system in a routine laboratory setting for molecular diagnosis of opportunistic viral infections: evaluation on whole blood specimens and proficiency panels. J. Virol. Methods 159:291-294.
21. Atabani SF, Smith C, Atkinson C, Aldridge RW, Rodriguez-Peralvarez M, Rolando N, Harber M, Jones G, O'Riordan A, Burroughs AK, Thorburn D, O'Beirne J, Milne RS, Emery VC, Griffiths PD. 2012. Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy. Am. J. Transplant. 12:2457-2464.
22. Muñoz-Cobo B, Solano C, Costa E, Bravo D, Clari MA, Benet I, Remigia MJ, Montoro J, Navarro D. 2011. Dynamics of cytomegalovirus (CMV) plasma DNA emia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies. Biol. Blood Marrow Transplant. 17:1602-1611.
23. Michelin BD, Hadzisejdic I, Bozic M, Grahovac M, Hess M, Grahovac B, Marth E, Kessler HH. 2008. Detection of cytomegalovirus (CMV) DNA in EDTA whole-blood samples: evaluation of the quantitative artus CMV LightCycler PCR kit in conjunction with automated sample preparation. J. Clin. Microbiol. 46:1241-1245.
24. Raggam RB, Bozic M, Salzer HJ, Hammerschmidt S, Homberg C, Ruzicka K, Kessler HH. 2010. Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR. Med. Microbiol. Immunol. 199:311-316.
25. Buyck HC, Griffiths PD, Emery VC. 2010. Human cytomegalovirus (HCMV) replication kinetics in stem cell transplant recipients following anti-HCMV therapy. J. Clin. Virol. 49:32-36.
26. Furione M, Rognoni V, Cabano E, Baldanti F. 2012. Kinetics of human cytomegalovirus (HCMV) DNA emia in transplanted patients expressed in international units as determined with the Abbott RealTime CMV assay and an in-house assay. J. Clin. Virol. 55:317-322.